AU2003246726A1 - Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 45 (gpr45) - Google Patents

Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 45 (gpr45)

Info

Publication number
AU2003246726A1
AU2003246726A1 AU2003246726A AU2003246726A AU2003246726A1 AU 2003246726 A1 AU2003246726 A1 AU 2003246726A1 AU 2003246726 A AU2003246726 A AU 2003246726A AU 2003246726 A AU2003246726 A AU 2003246726A AU 2003246726 A1 AU2003246726 A1 AU 2003246726A1
Authority
AU
Australia
Prior art keywords
gpr45
therapeutics
diagnostics
human
diseases associated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003246726A
Inventor
Ulf Bruggemeier
Stefan Golz
Holger Summer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer Healthcare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG
Publication of AU2003246726A1 publication Critical patent/AU2003246726A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003246726A 2002-07-31 2003-07-22 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 45 (gpr45) Abandoned AU2003246726A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02016897 2002-07-31
EP02016897.7 2002-07-31
PCT/EP2003/007957 WO2004013638A1 (en) 2002-07-31 2003-07-22 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 45 (gpr45)

Publications (1)

Publication Number Publication Date
AU2003246726A1 true AU2003246726A1 (en) 2004-02-23

Family

ID=31197780

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003246726A Abandoned AU2003246726A1 (en) 2002-07-31 2003-07-22 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 45 (gpr45)

Country Status (2)

Country Link
AU (1) AU2003246726A1 (en)
WO (1) WO2004013638A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106543280B (en) * 2015-09-22 2020-10-27 复旦大学 Specific antigen peptide aiming at GPR45 polyclonal antibody and preparation and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9794598A (en) * 1997-10-10 1999-05-03 Lxr Biotechnology Inc. Methods for detecting compounds which modulate the activity of an lpa receptor
US6210967B1 (en) * 1997-12-10 2001-04-03 Synaptic Pharmaceutical Corporation DNA encoding a mammalian LPA receptor and uses thereof
WO2002061087A2 (en) * 2000-12-19 2002-08-08 Lifespan Biosciences, Inc. Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides
JP2004526441A (en) * 2001-02-26 2004-09-02 アリーナ・フアーマシユーチカルズ・インコーポレーテツド Endogenous and non-endogenous human G protein-coupled receptors

Also Published As

Publication number Publication date
WO2004013638A1 (en) 2004-02-12

Similar Documents

Publication Publication Date Title
AU2003251471A1 (en) Diagnostics and therapeutics for diseases associated with human cxc chemokine receptor 5(cxcr5)
AU2003214072A1 (en) Diagnostics and therapeutics for diseases associated with the n-formyl peptide receptor 1 (fpr 1)
AU2003238339A1 (en) Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
AU2003240589A1 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 4 (gpr4)
AU2003250128A1 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 37 (gpr37)
AU2003246726A1 (en) Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 45 (gpr45)
AU2003276106A1 (en) Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 12 (gpr12)
AU2003273994A1 (en) Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43)
AU2003240720A1 (en) Diagnostics and therapeutics for diseases associated with somatostatin receptor 5 (sstr5)
AU2003267443A1 (en) Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 41 (gpr41)
AU2003274005A1 (en) Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 6 (gpr6)
AU2003301892A1 (en) Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 3 (gpr3)
AU2003229767A1 (en) Diagnostics and therapeutics for diseases associated with chemokine receptor 9(ccr9)
AU2003283266A1 (en) Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 14 (gpr14)
AU2003250165A1 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 19 (gpr19)
AU2003276097A1 (en) Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 42 (gpr42)
AU2003240721A1 (en) Diagnostics and therapeutics for diseases associated with somatostatin receptor 4(sstr4)
AU2003206749A1 (en) Diagnostics and therapeutics for diseases associated with the gpr65 receptor
AU2003219030A1 (en) Diagnostics and therapeutics for diseases associated with human g protein-coupled orphan receptor 21 (gpr21)
AU2003221502A1 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 10 (gpr10)
AU2003210382A1 (en) Diagnostic for diseases associated with g-protein coupled receptor 105 (gpr105)
AU2003238174A1 (en) Diagnostics and therapeutics for diseases associated with somatostatin receptor 3 (sstr3)
AU2003229736A1 (en) Diagnostics and therapeutics for diseases associated with neurotensin receptor 1 (nt1)
AU2003218638A1 (en) Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
AU2003229753A1 (en) Diagnostics and therapeutics for diseases associated with chemokine receptor 8 (ccr8)

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase